Lusedra

(Fospropofol)

PreclinicalSmall molecule

Eisai

Indications

Total Trials

Active Trials

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Clinical

Trials by Indication[1]

Anesthesia2 trials

Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery

Completed· Eisai logo

Eisai·Phase 2·NCT00209521·16 enrolled

ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia

Completed·TTongji Hospital·Phase 4·NCT06344325·330 enrolled

Prospective1 trial

Preventing Propofol Injection Pain: Prospective Randomized Trial Comparing Propofol Versus Fospropofol

Completed·NNYU Langone Health·Phase 4·NCT01401049·116 enrolled

Invasive Mechanical Ventilation1 trial

Safety and Efficacy of Fospropofol vs Propofol During Invasive Mechanical Ventilation.

Unknown status·HHenan Provincial People's Hospital·N/A·NCT06261996·200 enrolled

Laparoscopic Surgery1 trial

Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical Trial

Recruiting·HHui Xu·Phase 4·NCT06573489·373 enrolled

Sedation1 trial

Fospropofol for Sedation During Elective Awake Intubation

Withdrawn·TThe Cleveland Clinic·N/A·NCT01289483

Regulatory

FDA Approval Timeline[4]

Dec 12, 2008

LUSEDRA

NDA NDA022244

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Fospropofol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fospropofol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fospropofol. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA022244). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Eisai company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Eisai